Lumenato Nutritional Supplement on Skin Appearance
Completed · Not applicable
Conditions studied: Skin
In brief
This 12-week study is an open-label study assessing the perceived effectiveness of the Lycored Lumenato supplement on skin health and appearance.
Key facts
- Study ID
- NCT04248699
- Run by
- LycoRed Ltd.
- People needed
- 72
- Starts
- 2020-01-14
- Expected to finish
- 2020-07-08
- Last updated by the study team
- 2020-08-18
Who can join
Age: 35 and older, up to 55. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Resides in the United States
- Generally healthy women between the ages of 35-55
- Fitzpatrick skin types 2 or 3
- Identifies as one of the following: Asian, White, Hispanic/Latino, or both White and Hispanic/Latino
- Type 2 on the Glogau Skin Classification scale
- Has expressed interest in improving skin health and appearance
- Willing and able to follow the procedures of the study
- Willing to refrain from changing their diet or lifestyle significantly for the duration of the study
- Able to understand the study requirements and activities in English, and provide informed consent
- Access to reliable internet service and smartphone in order to utilize the ClaimIt software/app needed to remotely participate in the study
You may not qualify if…
- Participants with Fitzpatrick skin types of 1, 4, 5 or 6
- Known allergies or sensitivity to tomato, latex and/or potato
- Current use or use within 1 month of study enrollment of hormonal therapies (including hormonal contraceptives)
- Current, regular use or regular use within 1 month of study enrollment of oral steroids; regular use defined as >10 consecutive days
- Chronic or relapsing inflammatory and/or allergic skin conditions such as atopic dermatitis, rosacea, psoriasis and alike including telangiectasias ("spider veins")
- Pregnant, lactating or breastfeeding women (within the last 6 months) or those planning to become pregnant during the study period
- Less than 2 years since diagnosis or treatment of skin cancer including basal cell carcinoma, squamous cell carcinoma, melanoma- excluding actinic keratosis
- Currently active herpes infections or currently on treatment for herpes infections
- History of facial keloids
- Current diagnosis of adult acne or currently on treatment for adult acne
- Recent (<6 months at enrollment) cardiovascular conditions such as stroke, transient ischemic attack (TIA), or myocardial ischemia/infarction, recently on treatment for congestive heart failure, or currently having vasculitis or vascular conditions
- On potent blood thinners such as low-molecular weight heparin (LMWH), rivaroxaban, apixaban, or other prescription blood thinners - excludes aspirin
- Holds a current diagnosis of diabetes mellitus type I or II
- Participants who have received facial irradiation within last year or are planning on undergoing facial irradiation during the study
- Chronic liver disease- excluding early stage non-alcoholic fatty liver disease (NAFLD)
- Chronic kidney disease or recent (<6 months at enrollment) acute kidney disease
- Participants who currently take supplements containing carotenoids, lutein, melatonin or tryptophan
- Participants with occupations or lifestyle that require significant daily exposure to the sun (defined as at least 1 hour of continuous outdoor sun exposure)
- Participants who have had a sunburn in the last 2 weeks
- Participants who use tanning salons or tanning products in the last 3 months
- Participants who plan to undergo invasive facial procedures (injections, chemical peeling, etc.) during the study or have undergone these procedures within 2 months prior to enrollment
- Change in oral supplements or medications targeting skin health within 2 months prior to enrollment
- Participants who are HIV positive
- Participants who are immunosuppressed
- Participants with a recent (<2 months prior to enrollment) diagnosis of a psychiatric condition
Where it is running
- o ObvioHealth — Orlando, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.